smartphone-connected glucometer

By Aditi Pai 12:22 pm March 15, 2016
Israel-based LabStyle Innovations, maker of a smartphone-connected glucometer called Dario, has launched the device in the US, Dario secured its FDA 510(k) clearance in December. "The US is the world's largest market for glucose monitoring and the launch of national availability represents a transformative achievement not only for Dario, but more importantly for users," LabStyle Innovations CEO...
By Aditi Pai 09:18 am December 2, 2015
Philosys has received an FDA 510(k) clearance for the Android version of its smart glucometer companion app, called Gmate Smart. The device now works with Samsung Galaxy S3, S4, and S5 devices that have an Android operating system 4.0 or higher as well as Apple iPhone, iPod Touch, and iPad with iOS version 5.0 or higher. Philosys received an FDA clearance for the iOS app last year, in August, but...
By Aditi Pai 08:47 am November 17, 2015
San Jose, California-based Akibah just launched a crowdfunding campaign for its connected glucometer smartphone case, called GluCase. The company's CEO is Larry Ellingson, who was previously chair of the American Diabetes Association as well as executive director of diabetes care at pharma company Eli Lilly. GluCase stores all the tools that are normally included in a glucose meter kit including...
By Aditi Pai 09:33 am August 31, 2015
Israel-based LabStyle Innovations, maker of a smartphone-connected glucometer called Dario, has raised $2.5 million in common stock from Canadian investor Shmuel Farhi and others. This brings the company's total funding to at least $12.5 million. Dario is a small glucose meter that syncs with a companion app. It works with Apple iPhone 5, iPads and iPods and Android devices like the Samsung...
By Jonah Comstock 09:56 am May 4, 2015
Johnson & Johnson company LifeScan is launching a clinical trial to determine whether its OneTouch Verio blood glucose meter (or a not-yet-launched version of it) creates a greater reduction in A1C levels when used in conjunction with its companion app. According to a post on ClinicalTrials.gov, the company is recruiting 148 patients for a randomized control trial that will compare patients...